67.86
price up icon1.27%   +0.85
pre-market  Vorhandelsmarkt:  67.85   -0.01   -0.01%
loading

Finanzdaten der Gilead Sciences, Inc.-Aktie (GILD)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
0.89%
7,114.00
7,051.00 6,599.00 6,352.00 7,389.00
Cost Of Revenue
33.55%
2,090.00
1,565.00 1,442.00 1,401.00 1,396.00
Gross Profit
8.42%
5,024.00
5,486.00 5,157.00 4,951.00 5,993.00
Operating Expenses
19.18%
3,412.00
2,863.00 3,492.00 3,246.00 3,726.00
Interest Income/Expense
8.62%
252.00
232.00 230.00 230.00 226.00
Benefits Costs and Expenses
15.38%
5,461.00
4,733.00 5,011.00 5,052.00 5,358.00
Costs And Expenses
24.25%
5,502.00
4,428.00 4,934.00 4,647.00 5,122.00
Operating Income/Loss
38.54%
1,612.00
2,623.00 1,665.00 1,705.00 2,267.00
Nonoperating Income/Loss
506.94%
293.00
-72.00 152.00 -174.00 -10.00
Income/Loss From Continuing Operations Before Tax
28.69%
1,653.00
2,318.00 1,588.00 1,300.00 2,031.00
Income Tax Expense/Benefit, Deferred
444.12%
-370.00
-68.00 -221.00 -303.00 -338.00
Income Tax Expense/Benefit
62.33%
237.00
146.00 549.00 316.00 398.00
Income/Loss From Continuing Operations After Tax
34.81%
1,416.00
2,172.00 1,039.00 984.00 1,633.00
Net Income/Loss
34.76%
1,417.00
2,172.00 1,039.00 985.00 1,633.00
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
50.00%
-12.00
-8.00 -6.00 -26.00 -7.00
Basic Average Shares
100.08%
-1.00
1,248.00 1,249.00 1,248.00 -
Diluted Average Shares
100.08%
-1.00
1,257.00 1,258.00 1,261.00 1.00
Basic Earnings Per Share
34.29%
1.15
1.75 0.84 0.81 1.31
Diluted Earnings Per Share
34.68%
1.13
1.73 0.83 0.80 1.30
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
drug_manufacturers_general BMY
$44.11
price down icon 0.99%
drug_manufacturers_general GSK
$44.88
price down icon 1.79%
drug_manufacturers_general SNY
$48.82
price down icon 0.39%
drug_manufacturers_general PFE
$28.92
price up icon 0.35%
$314.72
price down icon 1.35%
drug_manufacturers_general NVS
$102.69
price down icon 0.51%
Kapitalisierung:     |  Volumen (24h):